Terkko Navigator / Syvälahti, E.

The effects of lorazepam on extrastriatal dopamine D(2/3)-receptors-A double-blind randomized placebo-controlled PET study

Update on current care guidelines. Depression, current care guideline

Laboratoriotutkimukset psykoosien ja mielialahäiriöiden lääkehoidon aikana

Quality of life and functioning ability in subjects vulnerable to psychosis

Psyykenläkehoito nuorisopsykiatriassa

Predicting medication-free treatment response in acute psychosis: cross-validation from the Finnish Need-Adapted Project

Combined treatment with citalopram and buspirone: effects on serotonin 5-HT2A and 5-HT2C receptors in the rat brain

Care and treatment of insomnia

Measurement of anticholinergic effects of psychotropic drugs in humans

Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man

The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal L-amino acid decarboxylase in healthy subjects

Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroid plexus after fluoxetine and citalopram treatments

Effects of fluoxetine on dopamine D2 receptors in the human brain: a positron emission tomography study with [11C]raclopride

Future directions for drug treatment of drug-resistant depression

The amygdala and schizophrenia: a volumetric magnetic resonance imaging study in first-episode, neuroleptic-naive patients

Regional brain morphology and duration of illness in never-medicated first-episode patients with schizophrenia

Ethanol consumption and DRD2 gene TaqI a polymorphism among socially drinking males

Personality traits and striatal dopamine synthesis capacity in healthy subjects

Ketamine does not decrease striatal dopamine D2 receptor binding in man

Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects

Structural magnetic resonance imaging in patients with first-episode schizophrenia, psychotic and severe non-psychotic depression and healthy controls. Results of the schizophrenia and affective psychoses (SAP) project

A volumetric MRI study of the entorhinal cortex in first episode neuroleptic-naive schizophrenia

Analysis of monoamine oxidase A (MAOA) promoter polymorphism in Finnish male alcoholics

Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia

Sertindole is a serotonin 5-HT2c inverse agonist and decreases agonist but not antagonist binding to 5-HT2c receptors after chronic treatment

The use of imaging techniques in drug research

A morphometric MRI study of the hippocampus in first-episode, neuroleptic-naïve schizophrenia

The effects of amitriptyline, citalopram and reboxetine on autonomic nervous system. A randomised placebo-controlled study on healthy volunteers

Differential effects of fluoxetine and citalopram treatments on serotonin 5-HT(2C) receptor occupancy in rat brain

Measurement of extrastriatal D2-like receptor binding with [11C]FLB 457--a test-retest analysis

Two-year outcome in first-episode psychosis treated according to an integrated model. Is immediate neuroleptisation always needed?

Lack of association between the functional variant of the catechol-o-methyltransferase (COMT) gene and early-onset alcoholism associated with severe antisocial behavior

High levels of dopamine activity in the basal ganglia of cigarette smokers

Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography

Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior

Brain 5-HT2A receptor occupancy of deramciclane in humans after a single oral administration--a positron emission tomography study

Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism

Measurement of striatal D2 dopamine receptor density and affinity with [11C]-raclopride in vivo: a test-retest analysis

Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia

Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo

Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography

Smoking and cognitive deficits in schizophrenia: a pilot study

Deramciclane, a putative anxiolytic drug, is a serotonin 5-HT2C receptor inverse agonist but fails to induce 5-HT2C receptor down-regulation

Is positive placebo response in chronic schizophrenia investigator-dependent?

Effects of lorazepam administration on striatal dopamine D2 receptor binding characteristics in man--a positron emission tomography study

Allelic association between D2 but not D1 dopamine receptor gene and alcoholism in Finland

Antagonist binding characteristics of the Ser311-->Cys variant of human dopamine D2 receptor in vivo and in vitro

Effect of smoking on neuroleptics in schizophrenia

Citalopram as an adjuvant in schizophrenia: further evidence for a serotonergic dimension in schizophrenia

Dopamine in schizophrenia